Invention Grant
- Patent Title: System for optimizing a patient's drug dosage regimen over time
-
Application No.: US14008911Application Date: 2012-03-29
-
Publication No.: US09619625B2Publication Date: 2017-04-11
- Inventor: Henrik Bengtsson
- Applicant: Henrik Bengtsson
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Wesley Nicolas
- Priority: EP11160340 20110330
- International Application: PCT/EP2012/055711 WO 20120329
- International Announcement: WO2012/130992 WO 20121004
- Main IPC: G06F19/00
- IPC: G06F19/00 ; A61M5/24 ; A61B5/145 ; A61M5/31

Abstract:
A system for optimizing a patient's basal insulin dosage regimen over time, adapted to (a) determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and (b) at the same time display blood glucose value data and the recommended amount data as a function of time.
Public/Granted literature
- US20140094743A1 System for Optimizing a Patient's Drug Dosage Regimen Over Time Public/Granted day:2014-04-03
Information query